Pharma & Healthcare
Global Newcastle Disease Vaccine Market Research Report 2025
- Mar 11, 25
- ID: 27758
- Pages: 89
- Figures: 91
- Views: 10
The global market for Newcastle Disease Vaccine was valued at US$ 336 million in the year 2024 and is projected to reach a revised size of US$ 420 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Newcastle Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newcastle Disease Vaccine.
The Newcastle Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Newcastle Disease Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Newcastle Disease Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Chicken
Duck & Goose
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Newcastle Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Newcastle Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newcastle Disease Vaccine.
The Newcastle Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Newcastle Disease Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Newcastle Disease Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Chicken
Duck & Goose
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Newcastle Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Newcastle Disease Vaccine Market Overview
1.1 Product Definition
1.2 Newcastle Disease Vaccine by Type
1.2.1 Global Newcastle Disease Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Newcastle Disease Vaccine by Application
1.3.1 Global Newcastle Disease Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Global Newcastle Disease Vaccine Market Size Estimates and Forecasts
1.4.1 Global Newcastle Disease Vaccine Revenue 2020-2031
1.4.2 Global Newcastle Disease Vaccine Sales 2020-2031
1.4.3 Global Newcastle Disease Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Newcastle Disease Vaccine Market Competition by Manufacturers
2.1 Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Newcastle Disease Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Newcastle Disease Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Newcastle Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Newcastle Disease Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Newcastle Disease Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Newcastle Disease Vaccine, Date of Enter into This Industry
2.8 Global Newcastle Disease Vaccine Market Competitive Situation and Trends
2.8.1 Global Newcastle Disease Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Newcastle Disease Vaccine Players Market Share by Revenue
2.8.3 Global Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Newcastle Disease Vaccine Market Scenario by Region
3.1 Global Newcastle Disease Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Newcastle Disease Vaccine Sales by Region: 2020-2031
3.2.1 Global Newcastle Disease Vaccine Sales by Region: 2020-2025
3.2.2 Global Newcastle Disease Vaccine Sales by Region: 2026-2031
3.3 Global Newcastle Disease Vaccine Revenue by Region: 2020-2031
3.3.1 Global Newcastle Disease Vaccine Revenue by Region: 2020-2025
3.3.2 Global Newcastle Disease Vaccine Revenue by Region: 2026-2031
3.4 North America Newcastle Disease Vaccine Market Facts & Figures by Country
3.4.1 North America Newcastle Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Newcastle Disease Vaccine Sales by Country (2020-2031)
3.4.3 North America Newcastle Disease Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Newcastle Disease Vaccine Market Facts & Figures by Country
3.5.1 Europe Newcastle Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Newcastle Disease Vaccine Sales by Country (2020-2031)
3.5.3 Europe Newcastle Disease Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Newcastle Disease Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Newcastle Disease Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Newcastle Disease Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Newcastle Disease Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Newcastle Disease Vaccine Market Facts & Figures by Country
3.7.1 Latin America Newcastle Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Newcastle Disease Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Newcastle Disease Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Newcastle Disease Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Newcastle Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Newcastle Disease Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Newcastle Disease Vaccine Sales by Type (2020-2031)
4.1.1 Global Newcastle Disease Vaccine Sales by Type (2020-2025)
4.1.2 Global Newcastle Disease Vaccine Sales by Type (2026-2031)
4.1.3 Global Newcastle Disease Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Newcastle Disease Vaccine Revenue by Type (2020-2031)
4.2.1 Global Newcastle Disease Vaccine Revenue by Type (2020-2025)
4.2.2 Global Newcastle Disease Vaccine Revenue by Type (2026-2031)
4.2.3 Global Newcastle Disease Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Newcastle Disease Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Newcastle Disease Vaccine Sales by Application (2020-2031)
5.1.1 Global Newcastle Disease Vaccine Sales by Application (2020-2025)
5.1.2 Global Newcastle Disease Vaccine Sales by Application (2026-2031)
5.1.3 Global Newcastle Disease Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Newcastle Disease Vaccine Revenue by Application (2020-2031)
5.2.1 Global Newcastle Disease Vaccine Revenue by Application (2020-2025)
5.2.2 Global Newcastle Disease Vaccine Revenue by Application (2026-2031)
5.2.3 Global Newcastle Disease Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Newcastle Disease Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merial
6.1.1 Merial Company Information
6.1.2 Merial Description and Business Overview
6.1.3 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merial Newcastle Disease Vaccine Product Portfolio
6.1.5 Merial Recent Developments/Updates
6.2 CEVA
6.2.1 CEVA Company Information
6.2.2 CEVA Description and Business Overview
6.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
6.2.5 CEVA Recent Developments/Updates
6.3 QYH Biotech
6.3.1 QYH Biotech Company Information
6.3.2 QYH Biotech Description and Business Overview
6.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
6.3.5 QYH Biotech Recent Developments/Updates
6.4 Ringpu Biology
6.4.1 Ringpu Biology Company Information
6.4.2 Ringpu Biology Description and Business Overview
6.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
6.4.5 Ringpu Biology Recent Developments/Updates
6.5 Yebio
6.5.1 Yebio Company Information
6.5.2 Yebio Description and Business Overview
6.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
6.5.5 Yebio Recent Developments/Updates
6.6 Harbin Veterinary Research Institute
6.6.1 Harbin Veterinary Research Institute Company Information
6.6.2 Harbin Veterinary Research Institute Description and Business Overview
6.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
6.6.5 Harbin Veterinary Research Institute Recent Developments/Updates
6.7 Merck Animal Health
6.7.1 Merck Animal Health Company Information
6.7.2 Merck Animal Health Description and Business Overview
6.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
6.7.5 Merck Animal Health Recent Developments/Updates
6.8 DHN
6.8.1 DHN Company Information
6.8.2 DHN Description and Business Overview
6.8.3 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 DHN Newcastle Disease Vaccine Product Portfolio
6.8.5 DHN Recent Developments/Updates
6.9 Zoetis
6.9.1 Zoetis Company Information
6.9.2 Zoetis Description and Business Overview
6.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
6.9.5 Zoetis Recent Developments/Updates
6.10 ChengDu Tecbond
6.10.1 ChengDu Tecbond Company Information
6.10.2 ChengDu Tecbond Description and Business Overview
6.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
6.10.5 ChengDu Tecbond Recent Developments/Updates
6.11 Elanco (Lohmann)
6.11.1 Elanco (Lohmann) Company Information
6.11.2 Elanco (Lohmann) Description and Business Overview
6.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
6.11.5 Elanco (Lohmann) Recent Developments/Updates
6.12 FATRO
6.12.1 FATRO Company Information
6.12.2 FATRO Description and Business Overview
6.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
6.12.5 FATRO Recent Developments/Updates
6.13 CAVAC
6.13.1 CAVAC Company Information
6.13.2 CAVAC Description and Business Overview
6.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
6.13.5 CAVAC Recent Developments/Updates
6.14 Vaksindo
6.14.1 Vaksindo Company Information
6.14.2 Vaksindo Description and Business Overview
6.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
6.14.5 Vaksindo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Newcastle Disease Vaccine Industry Chain Analysis
7.2 Newcastle Disease Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Newcastle Disease Vaccine Production Mode & Process Analysis
7.4 Newcastle Disease Vaccine Sales and Marketing
7.4.1 Newcastle Disease Vaccine Sales Channels
7.4.2 Newcastle Disease Vaccine Distributors
7.5 Newcastle Disease Vaccine Customer Analysis
8 Newcastle Disease Vaccine Market Dynamics
8.1 Newcastle Disease Vaccine Industry Trends
8.2 Newcastle Disease Vaccine Market Drivers
8.3 Newcastle Disease Vaccine Market Challenges
8.4 Newcastle Disease Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Newcastle Disease Vaccine by Type
1.2.1 Global Newcastle Disease Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Newcastle Disease Vaccine by Application
1.3.1 Global Newcastle Disease Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Global Newcastle Disease Vaccine Market Size Estimates and Forecasts
1.4.1 Global Newcastle Disease Vaccine Revenue 2020-2031
1.4.2 Global Newcastle Disease Vaccine Sales 2020-2031
1.4.3 Global Newcastle Disease Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Newcastle Disease Vaccine Market Competition by Manufacturers
2.1 Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Newcastle Disease Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Newcastle Disease Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Newcastle Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Newcastle Disease Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Newcastle Disease Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Newcastle Disease Vaccine, Date of Enter into This Industry
2.8 Global Newcastle Disease Vaccine Market Competitive Situation and Trends
2.8.1 Global Newcastle Disease Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Newcastle Disease Vaccine Players Market Share by Revenue
2.8.3 Global Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Newcastle Disease Vaccine Market Scenario by Region
3.1 Global Newcastle Disease Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Newcastle Disease Vaccine Sales by Region: 2020-2031
3.2.1 Global Newcastle Disease Vaccine Sales by Region: 2020-2025
3.2.2 Global Newcastle Disease Vaccine Sales by Region: 2026-2031
3.3 Global Newcastle Disease Vaccine Revenue by Region: 2020-2031
3.3.1 Global Newcastle Disease Vaccine Revenue by Region: 2020-2025
3.3.2 Global Newcastle Disease Vaccine Revenue by Region: 2026-2031
3.4 North America Newcastle Disease Vaccine Market Facts & Figures by Country
3.4.1 North America Newcastle Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Newcastle Disease Vaccine Sales by Country (2020-2031)
3.4.3 North America Newcastle Disease Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Newcastle Disease Vaccine Market Facts & Figures by Country
3.5.1 Europe Newcastle Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Newcastle Disease Vaccine Sales by Country (2020-2031)
3.5.3 Europe Newcastle Disease Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Newcastle Disease Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Newcastle Disease Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Newcastle Disease Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Newcastle Disease Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Newcastle Disease Vaccine Market Facts & Figures by Country
3.7.1 Latin America Newcastle Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Newcastle Disease Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Newcastle Disease Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Newcastle Disease Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Newcastle Disease Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Newcastle Disease Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Newcastle Disease Vaccine Sales by Type (2020-2031)
4.1.1 Global Newcastle Disease Vaccine Sales by Type (2020-2025)
4.1.2 Global Newcastle Disease Vaccine Sales by Type (2026-2031)
4.1.3 Global Newcastle Disease Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Newcastle Disease Vaccine Revenue by Type (2020-2031)
4.2.1 Global Newcastle Disease Vaccine Revenue by Type (2020-2025)
4.2.2 Global Newcastle Disease Vaccine Revenue by Type (2026-2031)
4.2.3 Global Newcastle Disease Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Newcastle Disease Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Newcastle Disease Vaccine Sales by Application (2020-2031)
5.1.1 Global Newcastle Disease Vaccine Sales by Application (2020-2025)
5.1.2 Global Newcastle Disease Vaccine Sales by Application (2026-2031)
5.1.3 Global Newcastle Disease Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Newcastle Disease Vaccine Revenue by Application (2020-2031)
5.2.1 Global Newcastle Disease Vaccine Revenue by Application (2020-2025)
5.2.2 Global Newcastle Disease Vaccine Revenue by Application (2026-2031)
5.2.3 Global Newcastle Disease Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Newcastle Disease Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merial
6.1.1 Merial Company Information
6.1.2 Merial Description and Business Overview
6.1.3 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merial Newcastle Disease Vaccine Product Portfolio
6.1.5 Merial Recent Developments/Updates
6.2 CEVA
6.2.1 CEVA Company Information
6.2.2 CEVA Description and Business Overview
6.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
6.2.5 CEVA Recent Developments/Updates
6.3 QYH Biotech
6.3.1 QYH Biotech Company Information
6.3.2 QYH Biotech Description and Business Overview
6.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
6.3.5 QYH Biotech Recent Developments/Updates
6.4 Ringpu Biology
6.4.1 Ringpu Biology Company Information
6.4.2 Ringpu Biology Description and Business Overview
6.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
6.4.5 Ringpu Biology Recent Developments/Updates
6.5 Yebio
6.5.1 Yebio Company Information
6.5.2 Yebio Description and Business Overview
6.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
6.5.5 Yebio Recent Developments/Updates
6.6 Harbin Veterinary Research Institute
6.6.1 Harbin Veterinary Research Institute Company Information
6.6.2 Harbin Veterinary Research Institute Description and Business Overview
6.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
6.6.5 Harbin Veterinary Research Institute Recent Developments/Updates
6.7 Merck Animal Health
6.7.1 Merck Animal Health Company Information
6.7.2 Merck Animal Health Description and Business Overview
6.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
6.7.5 Merck Animal Health Recent Developments/Updates
6.8 DHN
6.8.1 DHN Company Information
6.8.2 DHN Description and Business Overview
6.8.3 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 DHN Newcastle Disease Vaccine Product Portfolio
6.8.5 DHN Recent Developments/Updates
6.9 Zoetis
6.9.1 Zoetis Company Information
6.9.2 Zoetis Description and Business Overview
6.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
6.9.5 Zoetis Recent Developments/Updates
6.10 ChengDu Tecbond
6.10.1 ChengDu Tecbond Company Information
6.10.2 ChengDu Tecbond Description and Business Overview
6.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
6.10.5 ChengDu Tecbond Recent Developments/Updates
6.11 Elanco (Lohmann)
6.11.1 Elanco (Lohmann) Company Information
6.11.2 Elanco (Lohmann) Description and Business Overview
6.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
6.11.5 Elanco (Lohmann) Recent Developments/Updates
6.12 FATRO
6.12.1 FATRO Company Information
6.12.2 FATRO Description and Business Overview
6.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
6.12.5 FATRO Recent Developments/Updates
6.13 CAVAC
6.13.1 CAVAC Company Information
6.13.2 CAVAC Description and Business Overview
6.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
6.13.5 CAVAC Recent Developments/Updates
6.14 Vaksindo
6.14.1 Vaksindo Company Information
6.14.2 Vaksindo Description and Business Overview
6.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
6.14.5 Vaksindo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Newcastle Disease Vaccine Industry Chain Analysis
7.2 Newcastle Disease Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Newcastle Disease Vaccine Production Mode & Process Analysis
7.4 Newcastle Disease Vaccine Sales and Marketing
7.4.1 Newcastle Disease Vaccine Sales Channels
7.4.2 Newcastle Disease Vaccine Distributors
7.5 Newcastle Disease Vaccine Customer Analysis
8 Newcastle Disease Vaccine Market Dynamics
8.1 Newcastle Disease Vaccine Industry Trends
8.2 Newcastle Disease Vaccine Market Drivers
8.3 Newcastle Disease Vaccine Market Challenges
8.4 Newcastle Disease Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Newcastle Disease Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Newcastle Disease Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Newcastle Disease Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Newcastle Disease Vaccine Sales (M Doses) of Key Manufacturers (2020-2025)
Table 5. Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Newcastle Disease Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Newcastle Disease Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Newcastle Disease Vaccine Average Price (USD/K Doses) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Newcastle Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Newcastle Disease Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Newcastle Disease Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Newcastle Disease Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Newcastle Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newcastle Disease Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Newcastle Disease Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Newcastle Disease Vaccine Sales by Region (2020-2025) & (M Doses)
Table 18. Global Newcastle Disease Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Newcastle Disease Vaccine Sales by Region (2026-2031) & (M Doses)
Table 20. Global Newcastle Disease Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Newcastle Disease Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Newcastle Disease Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Newcastle Disease Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Newcastle Disease Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Newcastle Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Newcastle Disease Vaccine Sales by Country (2020-2025) & (M Doses)
Table 27. North America Newcastle Disease Vaccine Sales by Country (2026-2031) & (M Doses)
Table 28. North America Newcastle Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Newcastle Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Newcastle Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Newcastle Disease Vaccine Sales by Country (2020-2025) & (M Doses)
Table 32. Europe Newcastle Disease Vaccine Sales by Country (2026-2031) & (M Doses)
Table 33. Europe Newcastle Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Newcastle Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Newcastle Disease Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Newcastle Disease Vaccine Sales by Region (2020-2025) & (M Doses)
Table 37. Asia Pacific Newcastle Disease Vaccine Sales by Region (2026-2031) & (M Doses)
Table 38. Asia Pacific Newcastle Disease Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Newcastle Disease Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Newcastle Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Newcastle Disease Vaccine Sales by Country (2020-2025) & (M Doses)
Table 42. Latin America Newcastle Disease Vaccine Sales by Country (2026-2031) & (M Doses)
Table 43. Latin America Newcastle Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Newcastle Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Newcastle Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2020-2025) & (M Doses)
Table 47. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2026-2031) & (M Doses)
Table 48. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Newcastle Disease Vaccine Sales (M Doses) by Type (2020-2025)
Table 51. Global Newcastle Disease Vaccine Sales (M Doses) by Type (2026-2031)
Table 52. Global Newcastle Disease Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Newcastle Disease Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Newcastle Disease Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Newcastle Disease Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Newcastle Disease Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Newcastle Disease Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Newcastle Disease Vaccine Price (USD/K Doses) by Type (2020-2025)
Table 59. Global Newcastle Disease Vaccine Price (USD/K Doses) by Type (2026-2031)
Table 60. Global Newcastle Disease Vaccine Sales (M Doses) by Application (2020-2025)
Table 61. Global Newcastle Disease Vaccine Sales (M Doses) by Application (2026-2031)
Table 62. Global Newcastle Disease Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Newcastle Disease Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Newcastle Disease Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Newcastle Disease Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Newcastle Disease Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Newcastle Disease Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Newcastle Disease Vaccine Price (USD/K Doses) by Application (2020-2025)
Table 69. Global Newcastle Disease Vaccine Price (USD/K Doses) by Application (2026-2031)
Table 70. Merial Company Information
Table 71. Merial Description and Business Overview
Table 72. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 73. Merial Newcastle Disease Vaccine Product
Table 74. Merial Recent Developments/Updates
Table 75. CEVA Company Information
Table 76. CEVA Description and Business Overview
Table 77. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 78. CEVA Newcastle Disease Vaccine Product
Table 79. CEVA Recent Developments/Updates
Table 80. QYH Biotech Company Information
Table 81. QYH Biotech Description and Business Overview
Table 82. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 83. QYH Biotech Newcastle Disease Vaccine Product
Table 84. QYH Biotech Recent Developments/Updates
Table 85. Ringpu Biology Company Information
Table 86. Ringpu Biology Description and Business Overview
Table 87. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 88. Ringpu Biology Newcastle Disease Vaccine Product
Table 89. Ringpu Biology Recent Developments/Updates
Table 90. Yebio Company Information
Table 91. Yebio Description and Business Overview
Table 92. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 93. Yebio Newcastle Disease Vaccine Product
Table 94. Yebio Recent Developments/Updates
Table 95. Harbin Veterinary Research Institute Company Information
Table 96. Harbin Veterinary Research Institute Description and Business Overview
Table 97. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 98. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product
Table 99. Harbin Veterinary Research Institute Recent Developments/Updates
Table 100. Merck Animal Health Company Information
Table 101. Merck Animal Health Description and Business Overview
Table 102. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 103. Merck Animal Health Newcastle Disease Vaccine Product
Table 104. Merck Animal Health Recent Developments/Updates
Table 105. DHN Company Information
Table 106. DHN Description and Business Overview
Table 107. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 108. DHN Newcastle Disease Vaccine Product
Table 109. DHN Recent Developments/Updates
Table 110. Zoetis Company Information
Table 111. Zoetis Description and Business Overview
Table 112. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 113. Zoetis Newcastle Disease Vaccine Product
Table 114. Zoetis Recent Developments/Updates
Table 115. ChengDu Tecbond Company Information
Table 116. ChengDu Tecbond Description and Business Overview
Table 117. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 118. ChengDu Tecbond Newcastle Disease Vaccine Product
Table 119. ChengDu Tecbond Recent Developments/Updates
Table 120. Elanco (Lohmann) Company Information
Table 121. Elanco (Lohmann) Description and Business Overview
Table 122. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 123. Elanco (Lohmann) Newcastle Disease Vaccine Product
Table 124. Elanco (Lohmann) Recent Developments/Updates
Table 125. FATRO Company Information
Table 126. FATRO Description and Business Overview
Table 127. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 128. FATRO Newcastle Disease Vaccine Product
Table 129. FATRO Recent Developments/Updates
Table 130. CAVAC Company Information
Table 131. CAVAC Description and Business Overview
Table 132. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 133. CAVAC Newcastle Disease Vaccine Product
Table 134. CAVAC Recent Developments/Updates
Table 135. Vaksindo Company Information
Table 136. Vaksindo Description and Business Overview
Table 137. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 138. Vaksindo Newcastle Disease Vaccine Product
Table 139. Vaksindo Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Newcastle Disease Vaccine Distributors List
Table 143. Newcastle Disease Vaccine Customers List
Table 144. Newcastle Disease Vaccine Market Trends
Table 145. Newcastle Disease Vaccine Market Drivers
Table 146. Newcastle Disease Vaccine Market Challenges
Table 147. Newcastle Disease Vaccine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Newcastle Disease Vaccine
Figure 2. Global Newcastle Disease Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Newcastle Disease Vaccine Market Share by Type: 2024 & 2031
Figure 4. Live Vaccines Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global Newcastle Disease Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Newcastle Disease Vaccine Market Share by Application: 2024 & 2031
Figure 8. Chicken
Figure 9. Duck & Goose
Figure 10. Other
Figure 11. Global Newcastle Disease Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Newcastle Disease Vaccine Market Size (2020-2031) & (US$ Million)
Figure 13. Global Newcastle Disease Vaccine Sales (2020-2031) & (M Doses)
Figure 14. Global Newcastle Disease Vaccine Average Price (USD/K Doses) & (2020-2031)
Figure 15. Newcastle Disease Vaccine Report Years Considered
Figure 16. Newcastle Disease Vaccine Sales Share by Manufacturers in 2024
Figure 17. Global Newcastle Disease Vaccine Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Newcastle Disease Vaccine Players: Market Share by Revenue in Newcastle Disease Vaccine in 2024
Figure 19. Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Newcastle Disease Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Newcastle Disease Vaccine Sales Market Share by Country (2020-2031)
Figure 22. North America Newcastle Disease Vaccine Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Newcastle Disease Vaccine Sales Market Share by Country (2020-2031)
Figure 26. Europe Newcastle Disease Vaccine Revenue Market Share by Country (2020-2031)
Figure 27. Germany Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Newcastle Disease Vaccine Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Newcastle Disease Vaccine Revenue Market Share by Region (2020-2031)
Figure 34. China Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Newcastle Disease Vaccine Sales Market Share by Country (2020-2031)
Figure 45. Latin America Newcastle Disease Vaccine Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Newcastle Disease Vaccine Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Newcastle Disease Vaccine by Type (2020-2031)
Figure 55. Global Revenue Market Share of Newcastle Disease Vaccine by Type (2020-2031)
Figure 56. Global Newcastle Disease Vaccine Price (USD/K Doses) by Type (2020-2031)
Figure 57. Global Sales Market Share of Newcastle Disease Vaccine by Application (2020-2031)
Figure 58. Global Revenue Market Share of Newcastle Disease Vaccine by Application (2020-2031)
Figure 59. Global Newcastle Disease Vaccine Price (USD/K Doses) by Application (2020-2031)
Figure 60. Newcastle Disease Vaccine Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Newcastle Disease Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Newcastle Disease Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Newcastle Disease Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Newcastle Disease Vaccine Sales (M Doses) of Key Manufacturers (2020-2025)
Table 5. Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Newcastle Disease Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Newcastle Disease Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Newcastle Disease Vaccine Average Price (USD/K Doses) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Newcastle Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Newcastle Disease Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Newcastle Disease Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Newcastle Disease Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Newcastle Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newcastle Disease Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Newcastle Disease Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Newcastle Disease Vaccine Sales by Region (2020-2025) & (M Doses)
Table 18. Global Newcastle Disease Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Newcastle Disease Vaccine Sales by Region (2026-2031) & (M Doses)
Table 20. Global Newcastle Disease Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Newcastle Disease Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Newcastle Disease Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Newcastle Disease Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Newcastle Disease Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Newcastle Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Newcastle Disease Vaccine Sales by Country (2020-2025) & (M Doses)
Table 27. North America Newcastle Disease Vaccine Sales by Country (2026-2031) & (M Doses)
Table 28. North America Newcastle Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Newcastle Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Newcastle Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Newcastle Disease Vaccine Sales by Country (2020-2025) & (M Doses)
Table 32. Europe Newcastle Disease Vaccine Sales by Country (2026-2031) & (M Doses)
Table 33. Europe Newcastle Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Newcastle Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Newcastle Disease Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Newcastle Disease Vaccine Sales by Region (2020-2025) & (M Doses)
Table 37. Asia Pacific Newcastle Disease Vaccine Sales by Region (2026-2031) & (M Doses)
Table 38. Asia Pacific Newcastle Disease Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Newcastle Disease Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Newcastle Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Newcastle Disease Vaccine Sales by Country (2020-2025) & (M Doses)
Table 42. Latin America Newcastle Disease Vaccine Sales by Country (2026-2031) & (M Doses)
Table 43. Latin America Newcastle Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Newcastle Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Newcastle Disease Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2020-2025) & (M Doses)
Table 47. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2026-2031) & (M Doses)
Table 48. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Newcastle Disease Vaccine Sales (M Doses) by Type (2020-2025)
Table 51. Global Newcastle Disease Vaccine Sales (M Doses) by Type (2026-2031)
Table 52. Global Newcastle Disease Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Newcastle Disease Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Newcastle Disease Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Newcastle Disease Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Newcastle Disease Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Newcastle Disease Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Newcastle Disease Vaccine Price (USD/K Doses) by Type (2020-2025)
Table 59. Global Newcastle Disease Vaccine Price (USD/K Doses) by Type (2026-2031)
Table 60. Global Newcastle Disease Vaccine Sales (M Doses) by Application (2020-2025)
Table 61. Global Newcastle Disease Vaccine Sales (M Doses) by Application (2026-2031)
Table 62. Global Newcastle Disease Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Newcastle Disease Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Newcastle Disease Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Newcastle Disease Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Newcastle Disease Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Newcastle Disease Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Newcastle Disease Vaccine Price (USD/K Doses) by Application (2020-2025)
Table 69. Global Newcastle Disease Vaccine Price (USD/K Doses) by Application (2026-2031)
Table 70. Merial Company Information
Table 71. Merial Description and Business Overview
Table 72. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 73. Merial Newcastle Disease Vaccine Product
Table 74. Merial Recent Developments/Updates
Table 75. CEVA Company Information
Table 76. CEVA Description and Business Overview
Table 77. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 78. CEVA Newcastle Disease Vaccine Product
Table 79. CEVA Recent Developments/Updates
Table 80. QYH Biotech Company Information
Table 81. QYH Biotech Description and Business Overview
Table 82. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 83. QYH Biotech Newcastle Disease Vaccine Product
Table 84. QYH Biotech Recent Developments/Updates
Table 85. Ringpu Biology Company Information
Table 86. Ringpu Biology Description and Business Overview
Table 87. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 88. Ringpu Biology Newcastle Disease Vaccine Product
Table 89. Ringpu Biology Recent Developments/Updates
Table 90. Yebio Company Information
Table 91. Yebio Description and Business Overview
Table 92. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 93. Yebio Newcastle Disease Vaccine Product
Table 94. Yebio Recent Developments/Updates
Table 95. Harbin Veterinary Research Institute Company Information
Table 96. Harbin Veterinary Research Institute Description and Business Overview
Table 97. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 98. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product
Table 99. Harbin Veterinary Research Institute Recent Developments/Updates
Table 100. Merck Animal Health Company Information
Table 101. Merck Animal Health Description and Business Overview
Table 102. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 103. Merck Animal Health Newcastle Disease Vaccine Product
Table 104. Merck Animal Health Recent Developments/Updates
Table 105. DHN Company Information
Table 106. DHN Description and Business Overview
Table 107. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 108. DHN Newcastle Disease Vaccine Product
Table 109. DHN Recent Developments/Updates
Table 110. Zoetis Company Information
Table 111. Zoetis Description and Business Overview
Table 112. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 113. Zoetis Newcastle Disease Vaccine Product
Table 114. Zoetis Recent Developments/Updates
Table 115. ChengDu Tecbond Company Information
Table 116. ChengDu Tecbond Description and Business Overview
Table 117. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 118. ChengDu Tecbond Newcastle Disease Vaccine Product
Table 119. ChengDu Tecbond Recent Developments/Updates
Table 120. Elanco (Lohmann) Company Information
Table 121. Elanco (Lohmann) Description and Business Overview
Table 122. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 123. Elanco (Lohmann) Newcastle Disease Vaccine Product
Table 124. Elanco (Lohmann) Recent Developments/Updates
Table 125. FATRO Company Information
Table 126. FATRO Description and Business Overview
Table 127. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 128. FATRO Newcastle Disease Vaccine Product
Table 129. FATRO Recent Developments/Updates
Table 130. CAVAC Company Information
Table 131. CAVAC Description and Business Overview
Table 132. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 133. CAVAC Newcastle Disease Vaccine Product
Table 134. CAVAC Recent Developments/Updates
Table 135. Vaksindo Company Information
Table 136. Vaksindo Description and Business Overview
Table 137. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 138. Vaksindo Newcastle Disease Vaccine Product
Table 139. Vaksindo Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Newcastle Disease Vaccine Distributors List
Table 143. Newcastle Disease Vaccine Customers List
Table 144. Newcastle Disease Vaccine Market Trends
Table 145. Newcastle Disease Vaccine Market Drivers
Table 146. Newcastle Disease Vaccine Market Challenges
Table 147. Newcastle Disease Vaccine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Newcastle Disease Vaccine
Figure 2. Global Newcastle Disease Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Newcastle Disease Vaccine Market Share by Type: 2024 & 2031
Figure 4. Live Vaccines Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global Newcastle Disease Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Newcastle Disease Vaccine Market Share by Application: 2024 & 2031
Figure 8. Chicken
Figure 9. Duck & Goose
Figure 10. Other
Figure 11. Global Newcastle Disease Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Newcastle Disease Vaccine Market Size (2020-2031) & (US$ Million)
Figure 13. Global Newcastle Disease Vaccine Sales (2020-2031) & (M Doses)
Figure 14. Global Newcastle Disease Vaccine Average Price (USD/K Doses) & (2020-2031)
Figure 15. Newcastle Disease Vaccine Report Years Considered
Figure 16. Newcastle Disease Vaccine Sales Share by Manufacturers in 2024
Figure 17. Global Newcastle Disease Vaccine Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Newcastle Disease Vaccine Players: Market Share by Revenue in Newcastle Disease Vaccine in 2024
Figure 19. Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Newcastle Disease Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Newcastle Disease Vaccine Sales Market Share by Country (2020-2031)
Figure 22. North America Newcastle Disease Vaccine Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Newcastle Disease Vaccine Sales Market Share by Country (2020-2031)
Figure 26. Europe Newcastle Disease Vaccine Revenue Market Share by Country (2020-2031)
Figure 27. Germany Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Newcastle Disease Vaccine Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Newcastle Disease Vaccine Revenue Market Share by Region (2020-2031)
Figure 34. China Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Newcastle Disease Vaccine Sales Market Share by Country (2020-2031)
Figure 45. Latin America Newcastle Disease Vaccine Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Newcastle Disease Vaccine Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Newcastle Disease Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Newcastle Disease Vaccine by Type (2020-2031)
Figure 55. Global Revenue Market Share of Newcastle Disease Vaccine by Type (2020-2031)
Figure 56. Global Newcastle Disease Vaccine Price (USD/K Doses) by Type (2020-2031)
Figure 57. Global Sales Market Share of Newcastle Disease Vaccine by Application (2020-2031)
Figure 58. Global Revenue Market Share of Newcastle Disease Vaccine by Application (2020-2031)
Figure 59. Global Newcastle Disease Vaccine Price (USD/K Doses) by Application (2020-2031)
Figure 60. Newcastle Disease Vaccine Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232